Kato Pharmaceuticals Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • 2ndary - Private

Kato Pharmaceuticals General Information

Description

Operator of a clinical-stage bio-pharmaceutical platform designed to develop novel therapies for pathologies of the eye. The company's platform focuses on the unmet medical needs of the eye and offers therapies that separate the vitreous from the retina, enabling ophthalmologists to treat and reduce the risk of progression.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 26051 Merit Circle
  • Suite 102
  • Laguna Hills, CA 92653
  • United States
+1 (949)
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Vertical(s)
Corporate Office
  • 26051 Merit Circle
  • Suite 102
  • Laguna Hills, CA 92653
  • United States
+1 (949)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kato Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private Completed Generating Revenue
3. Later Stage VC (Series C) 25-Oct-2018 Completed Generating Revenue
2. Later Stage VC (Series B) 28-Jul-2016 $6.09M $9.8M Completed Generating Revenue
1. Early Stage VC (Series A) 15-May-2015 $3.75M $3.75M Completed Generating Revenue
To view Kato Pharmaceuticals’s complete valuation and funding history, request access »

Kato Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 260,601 $0.001000 8% $14.39 $14.39 1x $14.39 16.79%
To view Kato Pharmaceuticals’s complete cap table history, request access »

Kato Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a clinical-stage bio-pharmaceutical platform designed to develop novel therapies for pathologies of the eye.
Biotechnology
Laguna Hills, CA
10 As of 2019

Tarrytown, NY
 

Basel, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kato Pharmaceuticals Competitors (4)

One of Kato Pharmaceuticals’s 4 competitors is Regeneron Pharmaceuticals, a Formerly VC-backed company based in Tarrytown, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regeneron Pharmaceuticals Formerly VC-backed Tarrytown, NY
Novartis Corporation Basel, Switzerland
Roche Corporation Basel, Switzerland
Bayer Corporation Leverkusen, Germany
To view Kato Pharmaceuticals’s complete competitors history, request access »

Kato Pharmaceuticals Patents

Kato Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017313907-A1 Delivery of urea to cells of the macula and retina using liposome constructs Active 18-Aug-2016
AU-2017313907-B2 Delivery of urea to cells of the macula and retina using liposome constructs Active 18-Aug-2016
US-11052158-B2 Delivery of urea to cells of the macula and retina using liposome constructs Active 18-Aug-2016
US-20190184030-A1 Delivery of urea to cells of the macula and retina using liposome constructs Active 18-Aug-2016
EP-3302061-A1 Extended release urea compositions Inactive 05-Jun-2015 A61K31/17
To view Kato Pharmaceuticals’s complete patent history, request access »

Kato Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kato Pharmaceuticals FAQs

  • When was Kato Pharmaceuticals founded?

    Kato Pharmaceuticals was founded in 2011.

  • Where is Kato Pharmaceuticals headquartered?

    Kato Pharmaceuticals is headquartered in Laguna Hills, CA.

  • What is the size of Kato Pharmaceuticals?

    Kato Pharmaceuticals has 10 total employees.

  • What industry is Kato Pharmaceuticals in?

    Kato Pharmaceuticals’s primary industry is Biotechnology.

  • Is Kato Pharmaceuticals a private or public company?

    Kato Pharmaceuticals is a Private company.

  • What is Kato Pharmaceuticals’s current revenue?

    The current revenue for Kato Pharmaceuticals is .

  • How much funding has Kato Pharmaceuticals raised over time?

    Kato Pharmaceuticals has raised $17.8M.

  • Who are Kato Pharmaceuticals’s competitors?

    Regeneron Pharmaceuticals, Novartis, Roche, and Bayer are competitors of Kato Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process